Logo image of KRMD

KORU MEDICAL SYSTEMS INC (KRMD) Stock Fundamental Analysis

NASDAQ:KRMD - US7599101026 - Common Stock

4.38 USD
+0.27 (+6.57%)
Last: 8/22/2025, 8:20:15 PM
4.38 USD
0 (0%)
After Hours: 8/22/2025, 8:20:15 PM
Fundamental Rating

3

KRMD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. KRMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KRMD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KRMD had negative earnings in the past year.
KRMD had a negative operating cash flow in the past year.
In the past 5 years KRMD always reported negative net income.
KRMD had a negative operating cash flow in each of the past 5 years.
KRMD Yearly Net Income VS EBIT VS OCF VS FCFKRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

KRMD's Return On Assets of -17.69% is in line compared to the rest of the industry. KRMD outperforms 51.87% of its industry peers.
Looking at the Return On Equity, with a value of -27.32%, KRMD is in line with its industry, outperforming 57.75% of the companies in the same industry.
Industry RankSector Rank
ROA -17.69%
ROE -27.32%
ROIC N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
KRMD Yearly ROA, ROE, ROICKRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

KRMD has a Gross Margin of 63.15%. This is in the better half of the industry: KRMD outperforms 64.17% of its industry peers.
KRMD's Gross Margin has been stable in the last couple of years.
KRMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
KRMD Yearly Profit, Operating, Gross MarginsKRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

KRMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
KRMD has more shares outstanding than it did 1 year ago.
KRMD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KRMD has been reduced compared to a year ago.
KRMD Yearly Shares OutstandingKRMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
KRMD Yearly Total Debt VS Total AssetsKRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

KRMD has an Altman-Z score of 13.19. This indicates that KRMD is financially healthy and has little risk of bankruptcy at the moment.
KRMD has a better Altman-Z score (13.19) than 92.51% of its industry peers.
KRMD has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of KRMD (0.01) is better than 69.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 13.19
ROIC/WACCN/A
WACC8.9%
KRMD Yearly LT Debt VS Equity VS FCFKRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.91 indicates that KRMD has no problem at all paying its short term obligations.
KRMD has a Current ratio of 2.91. This is comparable to the rest of the industry: KRMD outperforms 58.82% of its industry peers.
A Quick Ratio of 2.25 indicates that KRMD has no problem at all paying its short term obligations.
KRMD's Quick ratio of 2.25 is in line compared to the rest of the industry. KRMD outperforms 55.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 2.25
KRMD Yearly Current Assets VS Current LiabilitesKRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

KRMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.00%, which is quite impressive.
The Revenue has grown by 19.57% in the past year. This is quite good.
Measured over the past years, KRMD shows a small growth in Revenue. The Revenue has been growing by 7.76% on average per year.
EPS 1Y (TTM)20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)19.57%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%20.94%

3.2 Future

Based on estimates for the next years, KRMD will show a very strong growth in Earnings Per Share. The EPS will grow by 32.12% on average per year.
KRMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.30% yearly.
EPS Next Y20.95%
EPS Next 2Y31.71%
EPS Next 3Y32.12%
EPS Next 5YN/A
Revenue Next Year18.53%
Revenue Next 2Y17.44%
Revenue Next 3Y16.3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KRMD Yearly Revenue VS EstimatesKRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
KRMD Yearly EPS VS EstimatesKRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KRMD. In the last year negative earnings were reported.
Also next year KRMD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRMD Price Earnings VS Forward Price EarningsKRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRMD Per share dataKRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

KRMD's earnings are expected to grow with 32.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.71%
EPS Next 3Y32.12%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KRMD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KORU MEDICAL SYSTEMS INC

NASDAQ:KRMD (8/22/2025, 8:20:15 PM)

After market: 4.38 0 (0%)

4.38

+0.27 (+6.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)N/A N/A
Inst Owners52.7%
Inst Owner ChangeN/A
Ins Owners7.65%
Ins Owner Change0.92%
Market Cap202.49M
Analysts80
Price Target5.71 (30.37%)
Short Float %3.25%
Short Ratio5.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)62.29%
Min EPS beat(2)24.59%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)37.77%
Min EPS beat(4)3.88%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)40.05%
EPS beat(12)12
Avg EPS beat(12)34.3%
EPS beat(16)15
Avg EPS beat(16)29.18%
Revenue beat(2)2
Avg Revenue beat(2)6.08%
Min Revenue beat(2)5.66%
Max Revenue beat(2)6.5%
Revenue beat(4)3
Avg Revenue beat(4)3.5%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)6.5%
Revenue beat(8)6
Avg Revenue beat(8)2.35%
Revenue beat(12)7
Avg Revenue beat(12)1.68%
Revenue beat(16)11
Avg Revenue beat(16)2.34%
PT rev (1m)1.82%
PT rev (3m)-1.75%
EPS NQ rev (1m)-62.5%
EPS NQ rev (3m)-18.18%
EPS NY rev (1m)0%
EPS NY rev (3m)20.92%
Revenue NQ rev (1m)-0.59%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)2.47%
Revenue NY rev (3m)2.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.5
P/FCF N/A
P/OCF N/A
P/B 12.25
P/tB 12.79
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.8
BVpS0.36
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.69%
ROE -27.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.15%
FCFM N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
F-Score5
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 177.3%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.91
Quick Ratio 2.25
Altman-Z 13.19
F-Score5
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)239.72%
Cap/Depr(5y)210.83%
Cap/Sales(3y)5.63%
Cap/Sales(5y)4.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y20.95%
EPS Next 2Y31.71%
EPS Next 3Y32.12%
EPS Next 5YN/A
Revenue 1Y (TTM)19.57%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%20.94%
Revenue Next Year18.53%
Revenue Next 2Y17.44%
Revenue Next 3Y16.3%
Revenue Next 5YN/A
EBIT growth 1Y32.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.93%
EBIT Next 3Y41.31%
EBIT Next 5YN/A
FCF growth 1Y67.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.78%
OCF growth 3YN/A
OCF growth 5YN/A